These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 3285829

  • 1. Renal pharmacodynamic effects of torasemide and furosemide in normal man.
    Dupont AG, Gerlo E, Van der Niepen P, Laekeman G, Piepsz A.
    Arzneimittelforschung; 1988 Jan; 38(1A):172-5. PubMed ID: 3285829
    [Abstract] [Full Text] [Related]

  • 2. Acute and chronic effects of torasemide in healthy volunteers.
    Lameire N, Dodion L.
    Arzneimittelforschung; 1988 Jan; 38(1A):167-71. PubMed ID: 3370064
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M.
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [Abstract] [Full Text] [Related]

  • 4. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
    Mourad G, Haecker W, Mion C.
    Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
    Gentilini P, La Villa G, Marra F, Carloni V, Melani L, Foschi M, Cotrozzi G, Quartini M, Chibbaro G, Tommasi AC, Bernareggi A, Simoni A, Buzzelli G, Laffi G.
    J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
    [Abstract] [Full Text] [Related]

  • 6. Effects of torasemide on renal haemodynamics and function in anaesthetized dogs.
    Uchida T, Hayashi K, Suzuki Y, Matsumura Y.
    Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):497-504. PubMed ID: 1914250
    [Abstract] [Full Text] [Related]

  • 7. Diuretic action of the novel loop diuretic torasemide in the presence of angiotensin II or endothelin-1 in anaesthetized dogs.
    Uchida T, Hayashi K, Kido H, Watanabe M.
    J Pharm Pharmacol; 1992 Jan; 44(1):39-43. PubMed ID: 1350626
    [Abstract] [Full Text] [Related]

  • 8. Renal effects of the high ceiling diuretic torasemide in rats and dogs.
    Ghys A, Denef J, Delarge J, Georges A.
    Arzneimittelforschung; 1985 Jan; 35(10):1527-31. PubMed ID: 4074408
    [Abstract] [Full Text] [Related]

  • 9. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J, Deger F, Douchamps J, Ducarne H, Herchuelz A.
    Eur J Clin Pharmacol; 1986 Jan; 31 Suppl():29-34. PubMed ID: 3536530
    [Abstract] [Full Text] [Related]

  • 10. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
    Liguori A, Casini A, Di Loreto M, Andreini I, Napoli C.
    Eur J Clin Pharmacol; 1999 Apr; 55(2):117-24. PubMed ID: 10335906
    [Abstract] [Full Text] [Related]

  • 11. Dose-response curve for torasemide in healthy volunteers.
    Scheen AJ.
    Arzneimittelforschung; 1988 Jan; 38(1A):156-9. PubMed ID: 3370061
    [Abstract] [Full Text] [Related]

  • 12. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J, Häcker W, Glocke M.
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [Abstract] [Full Text] [Related]

  • 13. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.
    Delarge J.
    Arzneimittelforschung; 1988 Jan; 38(1A):144-50. PubMed ID: 3370058
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
    Herchuelz A, Derenne F, Deger F, Juvent M, Van Ganse E, Staroukine M, Verniory A, Boeynaems JM, Douchamps J.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1175-81. PubMed ID: 2703968
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
    Dodion L, Ambroes Y, Lameire N.
    Eur J Clin Pharmacol; 1986 Mar; 31 Suppl():21-7. PubMed ID: 3780837
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K, Valsson F, Sellgren J, Ricksten SE.
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [Abstract] [Full Text] [Related]

  • 18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S.
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics and pharmacodynamics of torasemide.
    Knauf H, Mutschler E.
    Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.